Performed an autologous bone marrow transplant, using the patient’s own cells to reduce the chances of infection and rejection
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
Campaign launched to spread awareness regarding dengue prevention and control
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
Directs officials to ensure that challenges hampering their effective implementation are resolved early in coordination with states
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Shares and American Depositary Shares of Olink for $26.00 per Share
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
Subscribe To Our Newsletter & Stay Updated
